SOURCE: BioLife Remedies Inc.

January 29, 2007 16:56 ET

BioLife Remedies Inc. Announces Completion of Reverse Merger

GUANGZHOU, CHINA -- (MARKET WIRE) -- January 29, 2007 -- BioLife Remedies Inc. (PINKSHEETS: BLRS) announced today that it has completed its articles of merger with Emerson Oil and Gas Inc., a publicly traded company incorporated in the state of Nevada, and trading on the over-the-counter Pink Sheets. As a result of the reverse merger, the company changed its name to BioLife Remedies Inc. and was issued a new trading symbol.

The National Association of Security Dealers (NASD), the regulatory organization responsible for the operation and regulation of the NASDAQ and OTC stock markets, published on January 18, 2007, the name change to BioLife Remedies Inc. and issued BLRS as its trading symbol.

Under the terms of the reverse merger agreement, the shareholders of BioLife Remedies Inc., incorporated in Colorado, are entitled to one share in the merged company for every share they held in BioLife Remedies Inc.

About Bio Life Remedies, Inc.

BIO LIFE REMEDIES, INC. combines Traditional Chinese Medicine and Western academic research and development practices with the newest scientific technology to produce effective medical and health-care products to combat serious diseases. The Bio Life Group has developed 108 master medical formulas to treat various diseases including diabetes, prostateria, osteoporosis, cerebrovascular disease, cardiac vascular disease, hypertension, menopausal syndrome, and sexual disorders in men and women.

Please visit for more information.

Forward-Looking Statements

You should not place undue reliance on forward-looking statements in this press release. This press release contains forward-looking statements that involve risks and uncertainties. Words such as "will," "anticipates," "believes," "plans," "goal," "expects," "future," "intends," and similar expressions are used to identify these forward-looking statements. Actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including the risks we face as described in this press release.

Copyright © Hugin ASA 2007. All rights reserved.

Contact Information

  • For Further Information:

    Tel: 604-630-8881
    Toll Free: 1-866-630-8881